So if our CEO decides we need more Capital to complete the Mission- A2-73 greatest Drug ever brought to market- which is an obvious YES, than the question becomes where do you source that Capital?
Dr Missling is on record saying that the one year cash on hand is enough..
That means someone else is funding the pHase2/3 Human Trials..
Who or what that entity is ..we don't know..but the reality is ,
we have possibly 3 Phase 2/3 that are either being currently planned with guidance from the FDA, like Alzheimers, or being developed after dramatically positive animal testing and with help from very active Associations, MJFF-Parkinsons and Rett Syndrome Asocc.-Rett Syndrome.
Since our drug has proved safe, well tolerated, easy to create and to deliver, we have multiple other IND's which may go Phase 2/3 at any time..
Including but not limited to..
Any Seizure Oriented CNS; my guess is there are a minimum of 10 CNS diseases associated with seiazures, starting with Epilepsy.
Any Disease associated with Autism..
Any Disease Associated with Depression..(Insomnai, Anxiety)
We have yet to test A2-73 on tow other Major Critical Funcitions
which the Sigma 1 Ligand is intimately involved..
The HEART and the EYES..I have sent a request in to Anavex requesting any information on Blood Pressure? I will send one requesting Vision Testing..
So you have a Blockbuster Drug that Biogen has entered into a MAterial Agreement with.do you think this Material Agreement includes the terms of wht happens WHEN Biogen discoves that INDEED A2-73 DOES ALLOW for PROGENERATION of NERVE CELL PROTECTANTS? Yeah..They already negotiated what happens IF and WHEN.. You guys are not thinking what happens when BIOGEN says it's a go..Oh my..oh my...
Anavex NOW!
